Certified Advisory Corp raised its stake in shares of McKesson Co. (NYSE:MCK) by 12.6% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,089 shares of the company’s stock after purchasing an additional 122 shares during the period. Certified Advisory Corp’s holdings in McKesson were worth $120,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Nordea Investment Management AB lifted its holdings in shares of McKesson by 48.8% in the 3rd quarter. Nordea Investment Management AB now owns 3,300,839 shares of the company’s stock valued at $437,856,000 after acquiring an additional 1,082,398 shares during the last quarter. Pzena Investment Management LLC lifted its holdings in shares of McKesson by 11.4% in the 3rd quarter. Pzena Investment Management LLC now owns 3,160,195 shares of the company’s stock valued at $419,200,000 after acquiring an additional 323,485 shares during the last quarter. Baupost Group LLC MA lifted its holdings in shares of McKesson by 33.7% in the 3rd quarter. Baupost Group LLC MA now owns 2,175,700 shares of the company’s stock valued at $288,607,000 after acquiring an additional 548,000 shares during the last quarter. Kiltearn Partners LLP lifted its holdings in shares of McKesson by 9.1% in the 3rd quarter. Kiltearn Partners LLP now owns 2,040,651 shares of the company’s stock valued at $270,692,000 after acquiring an additional 170,753 shares during the last quarter. Finally, American Century Companies Inc. lifted its holdings in shares of McKesson by 13.6% in the 3rd quarter. American Century Companies Inc. now owns 1,735,496 shares of the company’s stock valued at $230,214,000 after acquiring an additional 207,533 shares during the last quarter. 85.33% of the stock is owned by institutional investors and hedge funds.
MCK has been the subject of a number of analyst reports. Royal Bank of Canada set a $155.00 price target on shares of McKesson and gave the company a “hold” rating in a report on Friday, October 26th. Barclays lowered their price target on shares of McKesson from $150.00 to $136.00 and set an “equal weight” rating for the company in a report on Friday, October 26th. ValuEngine raised shares of McKesson from a “strong sell” rating to a “sell” rating in a research report on Monday, October 29th. Morgan Stanley reduced their price objective on shares of McKesson from $142.00 to $130.00 and set an “equal weight” rating on the stock in a research report on Monday, December 3rd. Finally, Zacks Investment Research lowered shares of McKesson from a “hold” rating to a “sell” rating in a research report on Thursday, January 3rd. One research analyst has rated the stock with a sell rating, eight have given a hold rating and six have assigned a buy rating to the company’s stock. The company currently has an average rating of “Hold” and an average target price of $137.99.
McKesson stock opened at $128.49 on Monday. The company has a debt-to-equity ratio of 0.81, a quick ratio of 0.57 and a current ratio of 1.02. McKesson Co. has a 1-year low of $106.11 and a 1-year high of $160.87. The stock has a market capitalization of $24.65 billion, a P/E ratio of 10.18, a PEG ratio of 1.34 and a beta of 1.25.
McKesson (NYSE:MCK) last posted its quarterly earnings data on Thursday, January 31st. The company reported $3.40 earnings per share for the quarter, topping the Zacks’ consensus estimate of $3.18 by $0.22. McKesson had a negative net margin of 0.15% and a positive return on equity of 27.83%. The company had revenue of $56.21 billion for the quarter, compared to analyst estimates of $55.27 billion. During the same period in the prior year, the company posted $3.41 EPS. Sell-side analysts expect that McKesson Co. will post 13.55 EPS for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Monday, April 1st. Investors of record on Friday, March 1st will be given a $0.39 dividend. This represents a $1.56 dividend on an annualized basis and a yield of 1.21%. The ex-dividend date of this dividend is Thursday, February 28th. McKesson’s dividend payout ratio (DPR) is currently 12.36%.
McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. It operates in three segments: U.S. Pharmaceutical and Specialty Solutions, European Pharmaceutical Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs, as well as other healthcare-related products; and offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices.
Featured Article: What is a stock split?
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.